181 Aufrufe 181 0 Kommentare 0 Kommentare

    Vaccines Market worth $63.66 billion in 2030 with 4.8% CAGR | MarketsandMarkets - Seite 2

    By geography, the vaccines market is divided into North America, Europe, Asia Pacific (APAC), Latin America (LATAM), the Middle East, and Africa. In 2024, North America held the largest share of the global vaccines market, thanks to its strong healthcare infrastructure, robust government immunization programs, high adoption of advanced vaccine technologies like mRNA and recombinant platforms, and the presence of leading vaccine manufacturers. Additionally, substantial R&D investments, favorable reimbursement policies, and widespread public awareness campaigns on immunization further solidified the region's dominance. The increasing demand for both pediatric and adult vaccines, along with strong regulatory support and funding for pandemic preparedness, has also reinforced North America's leadership in the global market.

    Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=1155

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Merck KGaA!
    Long
    103,45€
    Basispreis
    0,75
    Ask
    × 14,34
    Hebel
    Zum Produkt
    Blatt
    Short
    117,81€
    Basispreis
    0,80
    Ask
    × 13,63
    Hebel
    Zum Produkt
    Blatt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Key players in the vaccines market include Merck & Co., Inc. (US), GSK Plc (UK), Pfizer, Inc. (US), Sanofi (France), AstraZeneca (UK), Johnson & Johnson Services Inc. (US), Emergent (US), Mitsubishi Tanabe Pharma Corporation (Japan), Serum Institute of India Pvt. Ltd (India), and CSL (Australia), among others.

    Merck & Co. Inc (US):

    The company emphasizes technologically advanced vaccines to sustain ongoing demand for its diverse product lineup. It also pursues both organic and inorganic growth strategies to uphold its market position. The acquisition of Themis Bioscience GmbH and Immune Design Corp. is a key strategic move to strengthen its stance in the vaccines market. Merck's vaccines division generated substantial revenue in 2024, with the highly popular GARDASIL/GARDASIL 9 vaccine, making Merck one of the top vaccine brands worldwide.

    Pfizer Inc (US)

    Pfizer Inc. is another leading player in the vaccines market. The company emphasizes its R&D capabilities to develop a pipeline of highly differentiated medicines and vaccines. Collaborations in industry for developing new vaccines are likely to positively influence the market position of the company.

    For more information, Inquire Now!

    Related Reports:

    Veterinary Vaccines Market

    Vaccine Adjuvants Market

    Allergy Diagnostics Market

    Drug Discovery Services Market

    Pharmaceutical Contract Manufacturing Market 

    Get access to the latest updates on Vaccines Companies and Vaccines Market Size

     Seite 2 von 3 




    PR Newswire (engl.)
    0 Follower
    Autor folgen

    Verfasst von PR Newswire (engl.)
    Vaccines Market worth $63.66 billion in 2030 with 4.8% CAGR | MarketsandMarkets - Seite 2 DELRAY BEACH, Fla., Sept. 2, 2025 /PRNewswire/ - The global Vaccines Market, valued at US$59.52 billion in 2024, stood at US$50.46 billion in 2025 and is projected to advance at a resilient CAGR of 4.8% from 2025 to 2030, culminating in a forecasted …